Considering the neuropathological findings in LRRK2 mutation carriers, one might speculate that both SNCA and MAPT genes, which in turn are associated with the risk of PD [47], may also affect the LRRK2-related phenotypic expression. Here, LRRK2 is linked to Parkinson disease.